GeneDx Holdings (WGS) Interest & Investment Income (2020 - 2026)

GeneDx Holdings (WGS) has reported Interest & Investment Income for 7 consecutive years, with -$1.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Interest & Investment Income fell 45.04% year-over-year to -$1.2 million in Q2 2026; TTM through Jun 2026 was -$3.0 million, a 0.47% change from a year earlier, with the FY2025 full-year figure at -$2.5 million, up 16.26% from the prior year.
• Interest & Investment Income was -$1.2 million for Q2 2026 at GeneDx Holdings, down from -$717000.0 in the prior quarter.
• Over five years, Interest & Investment Income peaked at $1.1 million in Q4 2022 and troughed at -$1.2 million in Q2 2026.
• A 5-year average of -$169500.0 and a median of -$579500.0 in 2024 frame the typical range for Interest & Investment Income.
• Across the five-year window, Interest & Investment Income soared 5063.64% in 2022 and tumbled 186.09% in 2023, its largest moves.
• Over 5 years, Interest & Investment Income stood at $1.1 million in 2022, then plunged by 186.09% to -$978000.0 in 2023, then rose by 28.63% to -$698000.0 in 2024, then gained by 25.5% to -$520000.0 in 2025, then slumped by 127.88% to -$1.2 million in 2026.
• The last three Interest & Investment Income figures came in at -$1.2 million (Q2 2026), -$717000.0 (Q1 2026), and -$520000.0 (Q4 2025), per Business Quant data.